Status:
TERMINATED
PROgastrine COlon DEpistage
Lead Sponsor:
ECS-Progastrin SA
Collaborating Sponsors:
Centre Hospitalier Princesse Grace
Conditions:
Colon Cancer Screening
Healthy Person
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
Dosage of progastrin in asymptomatic person participating in colon cancer screening
Detailed Description
For anyone who will participate in colon screening at the Princess Grace Hospital of Monaco and who has signed the informed consent document. A blood test will be performed in addition to the screenin...
Eligibility Criteria
Inclusion
- participant in colon cancer screening
- signing informed consent
Exclusion
- any major medical, psychiatric or addictive illness that would affect the informed consent process
- The consent of a representative is not allowed in this study
Key Trial Info
Start Date :
February 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 17 2021
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT03775473
Start Date
February 7 2019
End Date
December 17 2021
Last Update
January 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Princesse Grace, Monaco
Montpellier, MC, France, 34070 MONTPELLIER